Clinical Scorecard: Assessment of Airway Wall Contrast Enhancement Using Virtual Monoenergetic Imaging from Spectral CT

At a Glance

Key Highlights

• Inflammation in airway diseases can be indirectly measured by lung density and airway wall dimensions on CT.
• Spectral detector CT enables generation of iodine maps and virtual monoenergetic images to quantify contrast enhancement without requiring separate non-enhanced and enhanced scans.
• The spectral attenuation curve slope (λHU) derived from VMI allows quantification of lung parenchyma and airway wall enhancement across different contrast phases.

Guideline-Based Recommendations

Diagnosis

• Use non-enhanced CT acquisitions for lung density and airway dimension measurements to avoid contrast-related alterations.
• Consider spectral detector CT with VMI for assessing airway wall and lung parenchyma enhancement to characterize inflammatory activity.

Management

• Apply standardized contrast protocols and breath-hold techniques to ensure reproducible spectral CT imaging.
• Utilize quantitative software (e.g., YACTA) for lung and airway segmentation and measurement of attenuation parameters.

Monitoring & Follow-up

• Monitor changes in lung density, airway wall dimensions, and spectral attenuation slopes to assess inflammation and treatment response.
• Compare spectral attenuation curve slopes across non-enhanced and various contrast phases for comprehensive evaluation.

Risks

• Contrast material can alter lung density and airway measurements; careful protocol adherence is necessary.
• Higher radiation dose in systemic arterial phase CT (triple-rule-out protocol) should be justified by clinical need.

Patient & Prescribing Data

234 patients aged 54 ± 17 years undergoing chest spectral CT including non-enhanced and contrast-enhanced phases

Spectral detector CT with VMI allows quantification of airway wall and lung parenchyma enhancement, potentially aiding in the evaluation of inflammatory airway diseases.

Clinical Best Practices

• Perform spectral detector CT with dose modulation and inspiratory breath hold for optimal image quality.
• Use virtual monoenergetic images at multiple energy levels (40–160 keV) to analyze iodine-dependent attenuation.
• Segment lungs and airways using validated software to obtain quantitative measures such as mean lung density and airway wall attenuation.
• Aggregate airway generation data (G5–10) for sensitive detection of subsegmental airway changes.
• Ensure consistent acquisition protocols and post-processing to enable reliable comparison of enhancement across phases.

References

• Quantitative CT in lung diseases
• Spectral detector CT technology and applications
• Virtual monoenergetic imaging for iodine quantification
• YACTA software for lung and airway segmentation